Evidence for Efficacy of Antidepressants for Pain Is Limited
In 11 comparisons, antidepressants were efficacious, but they were inefficacious or evidence was inconclusive for 31 comparisons
In 11 comparisons, antidepressants were efficacious, but they were inefficacious or evidence was inconclusive for 31 comparisons
The table provided is a review of notable updates that occurred in January 2023 for investigational products in development.
Seena Fazel of the University of Oxford, UK, and colleagues at the Karolinska Institute in Sweden compared the medicated and non-medicated periods of over 1.4 million beta blocker users.
8.4 percent of adults took sleep meds every day or most days in last 30 days; women were more likely to take sleep meds than men
Exxua (previously named Travivo) is a novel oral serotonin 1A receptor agonist.
The updated recommendations include both nonpharmacologic and pharmacologic interventions for adults in the acute phase of MDD.
Lower use of psychotropic, antihypertensive, and asthma medications observed; association attenuated by body mass index
The approval was based on data from adequate and well-controlled studies with risperidone long-acting injection (intramuscular).
Period prevalence of all antipsychotic prescriptions increased 3.3 percent per year from 2000 to 2019
The table provided is a review of notable updates that occurred in December 2022 for investigational products in development.